How can we help? 913 548 990Call International patients Book an appointment ESEN
Dr François Quenet

Oncological Surgery

Dr François Quenet

Specialist in

  • Peritoneal Oncological Surgery.

  • Advanced Hepatobiliary and Retroperitoneal Oncological Surgery.

  • Pressurised intraperitoneal chemotherapy (PIPAC).

«My work in advanced peritoneal oncological surgery aims to broaden treatment options and offer genuine alternatives to patients with highly complex diagnoses.»
Book an appointment

Professional profile

Dr François Quenet is a specialist in oncological surgery, with a particular focus on the treatment of peritoneal carcinomatosis and highly complex abdominal tumours.

His clinical career has run in parallel with extensive research activity, including participation in and leadership of international multicentre clinical trials that have helped to define the role of cytoreductive surgery and intraperitoneal chemotherapy in the management of malignant peritoneal disease. He regards advanced surgery as an act requiring the utmost technical precision, underpinned by prudent decision-making, clear communication and a deep respect for the patient’s human experience.

Education

His medical training is underpinned by a solid academic foundation and advanced specialisation in general and oncological surgery.

1992 | Doctor of Medicine and specialist in General Surgery and Visceral Surgery. Montpellier Faculty of Medicine.
1986 | Former junior doctor at the hospitals in Montpellier (competitive examination).
1986 | Bachelor’s degree in Medicine and Surgery. Montpellier Faculty of Medicine.

Professional experience

He has carried out his clinical and leadership work at leading centres for oncological surgery.

Current position | Specialist in oncological surgery. Quenet Torrent Institute.

1995 – Present | Oncological surgeon. Montpellier Cancer Centre (ICM). • Head of the Hepatobiliary and Peritoneal Carcinomatosis Surgery Unit. • Responsible for multidisciplinary consensus meetings (RCP). • Scientific coordinator for clinical research programmes on peritoneal carcinomatosis. • Responsible for the clinical-biological database on peritoneal carcinomatosis.
2008 – 2012 | National Secretary of the Group of Centre Surgeons.

Scientific publications

His most significant scientific publications include leading international clinical trials in peritoneal oncological surgery.

2024 | Classe JM, Meeus P, Quenet F, et al. Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial. The Lancet Oncology. 2024;25(12):1551–1562. DOI: 10.1016/S1470-2045(24)00531-X
2021 | Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7). The Lancet Oncology. 2021;22(2):256–266. DOI: 10.1016/S1470-2045(20)30599-4
2020 | Goéré D, Glehen O, Quenet F, et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15). The Lancet Oncology. 2020;21(9):1147–1154. DOI: 10.1016/S1470-2045(20)30322-3

Areas of special focus

The clinical areas in which we specialise most include the following complex oncological conditions:

  • Peritoneal carcinomatosis of colorectal origin.
  • Liver and biliary tract tumours.
  • Retroperitoneal tumours requiring complex resection.
  • Peritoneal pseudomixoma.
  • Sarcomas and mesenchymal tumours.

Techniques and procedures

He routinely performs advanced surgical techniques in peritoneal oncological surgery.

  • Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC).
  • Advanced surgery for hepatobiliary and retroperitoneal tumours.
  • Combined multidisciplinary surgical techniques.
  • Resection of retroperitoneal sarcomas.
  • Pressurised intraperitoneal chemotherapy (PIPAC).

Accreditations and memberships

He is a member of leading international scientific societies specialising in oncological surgery.

  • RENAPE (National Network for the Treatment of Peritoneal Carcinomatosis).
  • European Society of Surgical Oncology (ESSO).
  • Peritoneal Surface Oncology Group International (PSOGI).

Request an appointment with Dr François Quenet

Specialist assessment with personalised planning and support throughout the entire process.

Book an appointment
Call Book now